185 related articles for article (PubMed ID: 18465212)
1. Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.
Ibekwe VC; Fadda HM; McConnell EL; Khela MK; Evans DF; Basit AW
Pharm Res; 2008 Aug; 25(8):1828-35. PubMed ID: 18465212
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans.
Ibekwe VC; Liu F; Fadda HM; Khela MK; Evans DF; Parsons GE; Basit AW
J Pharm Sci; 2006 Dec; 95(12):2760-6. PubMed ID: 16917845
[TBL] [Abstract][Full Text] [Related]
3. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
4. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
5. Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state.
Pišlar M; Brelih H; Mrhar A; Bogataj M
Eur J Pharm Sci; 2015 Jul; 75():131-41. PubMed ID: 25769525
[TBL] [Abstract][Full Text] [Related]
6. Meal-induced acceleration of tablet transit through the human small intestine.
Fadda HM; McConnell EL; Short MD; Basit AW
Pharm Res; 2009 Feb; 26(2):356-60. PubMed ID: 18982248
[TBL] [Abstract][Full Text] [Related]
7. Scintigraphic evaluation of the in vivo performance of dry-coated delayed-release tablets in humans.
Kambayashi A; Sako K; Kondo H
Eur J Pharm Biopharm; 2020 Jul; 152():116-122. PubMed ID: 32380166
[TBL] [Abstract][Full Text] [Related]
8. A new concept in colonic drug targeting: a combined pH-responsive and bacterially-triggered drug delivery technology.
Ibekwe VC; Khela MK; Evans DF; Basit AW
Aliment Pharmacol Ther; 2008 Oct; 28(7):911-6. PubMed ID: 18647282
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets.
Maurer JM; Schellekens RC; van Rieke HM; Wanke C; Iordanov V; Stellaard F; Wutzke KD; Dijkstra G; van der Zee M; Woerdenbag HJ; Frijlink HW; Kosterink JG
PLoS One; 2015; 10(7):e0129076. PubMed ID: 26177019
[TBL] [Abstract][Full Text] [Related]
10. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man.
McConnell EL; Short MD; Basit AW
J Control Release; 2008 Sep; 130(2):154-60. PubMed ID: 18639950
[TBL] [Abstract][Full Text] [Related]
11. Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System.
Koziolek M; Grimm M; Becker D; Iordanov V; Zou H; Shimizu J; Wanke C; Garbacz G; Weitschies W
J Pharm Sci; 2015 Sep; 104(9):2855-63. PubMed ID: 25411065
[TBL] [Abstract][Full Text] [Related]
12. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.
Wilding IR; Hardy JG; Sparrow RA; Davis SS; Daly PB; English JR
Pharm Res; 1992 Nov; 9(11):1436-41. PubMed ID: 1475230
[TBL] [Abstract][Full Text] [Related]
14. Characterization of colonic transit of nondisintegrating tablets in healthy subjects.
Price JM; Davis SS; Wilding IR
Dig Dis Sci; 1993 Jun; 38(6):1015-21. PubMed ID: 8389686
[TBL] [Abstract][Full Text] [Related]
15. Scintigraphic measurement of regional gastrointestinal transit in the dog.
Iwanaga Y; Wen J; Thollander MS; Kost LJ; Thomforde GM; Allen RG; Phillips SF
Am J Physiol; 1998 Nov; 275(5):G904-10. PubMed ID: 9815018
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers.
Katsuma M; Watanabe S; Takemura S; Sako K; Sawada T; Masuda Y; Nakamura K; Fukui M; Connor AL; Wilding IR
J Pharm Sci; 2004 May; 93(5):1287-99. PubMed ID: 15067705
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.
Podczeck F; Course N; Newton JM; Short MB
J Pharm Pharmacol; 2007 Jul; 59(7):941-5. PubMed ID: 17637188
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
[TBL] [Abstract][Full Text] [Related]
19. Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
Stevens HN; Speakman M
Curr Med Res Opin; 2006 Dec; 22(12):2323-8. PubMed ID: 17257446
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal transit of an enteric-coated delayed-release 5-aminosalicylic acid tablet.
Hardy JG; Healey JN; Lee SW; Reynolds JR
Aliment Pharmacol Ther; 1987 Jun; 1(3):209-16. PubMed ID: 2979223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
